Gene Editing: Exa-Cel Panel Review Raises Practical Concerns About Theoretical Risks

 
• By Sue Sutter
  
Mountain terrain
The exa-cel adcomm found itself navigating new terrain of practical concerns befitting the cutting-edge technology involved. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers